Cellbricks Therapeutics secured €5 million in venture capital and research funding with VU Venture Partners and ACT Venture Partners

Health services Manufacturing

Investments

25 September 2024

Cellbricks Therapeutics (company)

Health services Manufacturing

Total investments received (USD): 13.83m

Round value (USD): 5.55m

Round investors: VU Venture Partners ACT Venture Partners Can Gerling

Industry: Health services Manufacturing

Biotech Hardware Health services Manufacturing

Investments 08 February 2025

Health services Manufacturing Pharma

Investments 29 November 2024

Health services Manufacturing Robotics

Investments 06 September 2024

Biotech Health services Manufacturing

Investments 02 August 2024

Biotech Health services Manufacturing Pharma

Investments 04 June 2024